TipRanks
Go Ultimate55% OFF

Boiron SA (BON) Stock Price & Analysis

BON Stock Chart & Stats

€18.30€0.20(1.10%)
At close: 1:00 AM GMT+1
€26€27€28€2928 May9 Jun3 Jul26 Aug
Day’s Range
EUR 18.30 - EUR 18.30
52-Week Range
EUR 16.50 - EUR 31.35
Previous Close
EUR 18.10
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 327.60M
Enterprise Value
EUR 454.08M
Total Cash (Recent Filing)
EUR 50.67M
Total Debt (Recent Filing)
EUR 23.80M
Price to Earnings (P/E)
12.6
Beta
-0.07
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
7.32%

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage gives Boiron substantial financial flexibility and reduces the burden of interest and refinancing costs. This conservative capital structure can help the company withstand operating volatility while preserving capacity to invest, maintain products, or return cash to shareholders.

Positive Cash Generation

Positive operating and free cash flow across the reported periods indicates that Boiron’s operations have generally converted activity into internally generated funds. That supports ongoing business needs and provides a durable funding source, even though the pace of cash generation varies.

Established Pharmacy Distribution

A branded consumer-health portfolio supported by pharmacy distribution gives Boiron an established route to customers and recurring access to self-managed healthcare demand. Its domestic and international footprint can support resilience by spreading sales across channels and geographies.

Bears Say

Severe Revenue Contraction

The severe reported 2025 revenue contraction and broader history of uneven declines weaken visibility into Boiron’s underlying demand. Persistent top-line instability can limit operating leverage, complicate planning, and make future earnings less dependable even when profitability improves.

Volatile Free Cash Flow

Sharp year-to-year swings and the 2025 free-cash-flow decline make internally generated funding less predictable. Lower cash conversion consistency can constrain reinvestment and shareholder distributions, while increasing reliance on the company’s balance-sheet flexibility during weaker operating periods.

Shrinking Asset Base

Declining assets and equity, combined with an uneven profit trajectory, suggest that the company’s financial base has not expanded consistently. If this pattern persists, it could reduce capacity to support growth and leave future returns more dependent on stabilizing operations.

BON FAQ

What was Boiron SA’s price range in the past 12 months?
Boiron SA lowest stock price was €16.50 and its highest was €31.35 in the past 12 months.
What is Boiron SA’s market cap?
Boiron SA’s market cap is €327.60M.
When is Boiron SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Boiron SA’s earnings last quarter?
Boiron SA released its earnings results on Sep 09, 2026. The company reported €0.283 earnings per share for the quarter.
Is Boiron SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Boiron SA pay dividends?
Boiron SA does not currently pay dividends.
What is Boiron SA’s EPS estimate?
Boiron SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Boiron SA have?
Boiron SA has 17,545,408 shares outstanding.
What happened to Boiron SA’s price movement after its last earnings report?
Boiron SA reported an EPS of €0.283 in its last earnings report. Following the earnings report the stock price went up 0.386%.
Which hedge fund is a major shareholder of Boiron SA?
Currently, no hedge funds are holding shares in DE:BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology